Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | AZN | AMGN | GILD | BMY |
| Company | Adverum Biotechnologies Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.24 | 183.08 | 331.01 | 130.67 | 56.16 |
| High | 4.38 | 183.08 | 331.01 | 130.67 | 56.16 |
| Low | 4.23 | 183.08 | 331.01 | 130.67 | 56.16 |
| Latest | 4.36 | 183.08 | 331.01 | 130.67 | 56.16 |
| Change | +0.10 | +0.23 | -0.69 | -0.66 | unch |
| % Change | +2.35% | +0.13% | -0.21% | -0.50% | unch |
| Volume | 1,023,000 | 31,834 | 3,142 | 6,522 | 4,189 |
| 20-Day Average Volume | 498,235 | 2,010,072 | 2,542,037 | 5,819,741 | 9,746,475 |
| Previous Close | 4.26 | 182.85 | 331.70 | 131.33 | 56.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.22 | 190.69 | 340.41 | 133.47 | 58.10 |
| 20-Day Raw Stochastic | 95.22% | 12.17% | 28.83% | 22.02% | 11.31% |
| 20-Day Relative Strength | 55.48 | 40.16 | 41.35 | 41.57 | 42.65 |
| Weighted Alpha | -8.15 | +25.73 | +16.28 | +21.25 | +19.52 |
| Today's Opinion | 64% Buy | 8% Sell | 8% Sell | 8% Sell | 24% Buy |
| Previous Opinion | 56% Buy | 8% Sell | 8% Sell | 8% Sell | 24% Buy |
| Last Month's Opinion | 72% Buy | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.81% since 12/01/25 | -0.21% since 05/04/26 | +2.21% since 05/04/26 | -1.52% since 05/04/26 | -2.13% since 05/04/26 |
| Low | 4.15 on 12/05/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 129.00 on 05/08/26 | 55.57 on 05/07/26 |
| High | 4.38 on 12/08/25 | 185.61 on 05/06/26 | 332.98 on 05/06/26 | 136.75 on 05/06/26 | 57.48 on 05/05/26 |
| 1-Month | |||||
| %Chg | +0.93% since 11/07/25 | -10.27% since 04/10/26 | -5.70% since 04/10/26 | -5.99% since 04/10/26 | -4.20% since 04/10/26 |
| Low | 3.99 on 11/25/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 4.38 on 12/08/25 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +23.16% since 09/08/25 | -10.59% since 02/11/26 | -9.70% since 02/11/26 | -16.13% since 02/11/26 | -6.29% since 02/11/26 |
| Low | 2.87 on 09/17/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 5.75 on 10/02/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +54.06% since 06/06/25 | +2.75% since 11/11/25 | -2.20% since 11/11/25 | +6.62% since 11/11/25 | +15.27% since 11/11/25 |
| Low | 2.11 on 07/01/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 5.75 on 10/02/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 96,256 | 283,583,520 | 179,013,520 | 163,009,696 | 114,682,712 |
| Shares Outstanding, K | 22,077 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 1,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -130,930,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -47,650,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.87 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.03 on 11/12/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 04/21/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.71 | 14.89 | 16.02 | 9.49 |